These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12007738)

  • 41. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.
    Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL
    Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
    Spradley FT; Tan AY; Joo WS; Daniels G; Kussie P; Karumanchi SA; Granger JP
    Hypertension; 2016 Apr; 67(4):740-7. PubMed ID: 26831193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis.
    Barillari G; Albonici L; Franzese O; Modesti A; Liberati F; Barillari P; Ensoli B; Manzari V; Santeusanio G
    Am J Pathol; 1998 May; 152(5):1161-6. PubMed ID: 9588884
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Placenta growth factor is not required for exercise-induced angiogenesis.
    Gigante B; Tarsitano M; Cimini V; De Falco S; Persico MG
    Angiogenesis; 2004; 7(3):277-84. PubMed ID: 15609082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of evidence for PlGF mediating the tumor resistance after anti-angiogenic therapy in malignant gliomas.
    Schneider K; Weyerbrock A; Doostkam S; Plate K; Machein MR
    J Neurooncol; 2015 Jan; 121(2):269-78. PubMed ID: 25370707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism.
    Yao YG; Yang HS; Cao Z; Danielsson J; Duh EJ
    FEBS Lett; 2005 Feb; 579(5):1227-34. PubMed ID: 15710418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Placenta growth factor is a survival factor for human malignant mesothelioma cells.
    Albonici L; Doldo E; Palumbo C; Orlandi A; Bei R; Pompeo E; Mineo TC; Modesti A; Manzari V
    Int J Immunopathol Pharmacol; 2009; 22(2):389-401. PubMed ID: 19505392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Porcine placental immunoexpression of vascular endothelial growth factor, placenta growth factor, Flt-1 and Flk-1.
    Sanchis EG; Cristofolini AL; Merkis CI
    Biotech Histochem; 2015; 90(7):486-94. PubMed ID: 25968146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determinants of placental vascularity.
    Torry DS; Hinrichs M; Torry RJ
    Am J Reprod Immunol; 2004 Apr; 51(4):257-68. PubMed ID: 15212678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maternal and foetal angiogenic imbalance in congenital heart defects.
    Llurba E; Sánchez O; Ferrer Q; Nicolaides KH; Ruíz A; Domínguez C; Sánchez-de-Toledo J; García-García B; Soro G; Arévalo S; Goya M; Suy A; Pérez-Hoyos S; Alijotas-Reig J; Carreras E; Cabero L
    Eur Heart J; 2014 Mar; 35(11):701-7. PubMed ID: 24159191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiogenic growth factor expression in placenta.
    Smith SK; He Y; Clark DE; Charnock-Jones DS
    Semin Perinatol; 2000 Feb; 24(1):82-6. PubMed ID: 10709867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential.
    Cianfarani F; Zambruno G; Brogelli L; Sera F; Lacal PM; Pesce M; Capogrossi MC; Failla CM; Napolitano M; Odorisio T
    Am J Pathol; 2006 Oct; 169(4):1167-82. PubMed ID: 17003476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Automated evaluation of angiogenic effects mediated by VEGF and PlGF homo- and heterodimers.
    Kurz H; Wilting J; Sandau K; Christ B
    Microvasc Res; 1998 Jan; 55(1):92-102. PubMed ID: 9473412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.
    Maglione D; Guerriero V; Viglietto G; Delli-Bovi P; Persico MG
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9267-71. PubMed ID: 1924389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders.
    Luttun A; Tjwa M; Carmeliet P
    Ann N Y Acad Sci; 2002 Dec; 979():80-93. PubMed ID: 12543719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Placental growth factor enhances angiogenesis in human intestinal microvascular endothelial cells via PI3K/Akt pathway: Potential implications of inflammation bowel disease.
    Zhou Y; Tu C; Zhao Y; Liu H; Zhang S
    Biochem Biophys Res Commun; 2016 Feb; 470(4):967-74. PubMed ID: 26775845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of placenta growth factor in cancer and inflammation.
    Kim KJ; Cho CS; Kim WU
    Exp Mol Med; 2012 Jan; 44(1):10-9. PubMed ID: 22217448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review.
    Ahmed A; Dunk C; Ahmad S; Khaliq A
    Placenta; 2000; 21 Suppl A():S16-24. PubMed ID: 10831117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells.
    Marrony S; Bassilana F; Seuwen K; Keller H
    Bone; 2003 Sep; 33(3):426-33. PubMed ID: 13678785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.